drugset / Trial / NCT00616954

A Study to Evaluate the Effect of ATG-F on Engraftment, Graft Versus Host Disease (GVHD) and Graft Versus Leukemia (GVL) Effect in Haplo-identical SCT

NCT00616954 ↗

Phase 3 Terminated 50 enrolled Hadassah Medical Organization
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is planned to evaluated whether ATG is needed in haploidentical stem cell transplantation

Timeline

Start
2008-05
Primary completion
2010-06
Completion
2010-09

Outcome

Outcome not reported

Stopped (Enrollment): “low recruitment”

Drugs

EvaluationDrugModalityDoseRoute
Subject ATG-F Unknown — —